Atrial Fibrillation Trial, Recruiting NCT06560047 Sponsor: Aalborg University Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06560047
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with heart failure where the heart pumps less effectively than normal (called "reduced ejection fraction"), and your heart's pumping strength has been measured at below 50% at some point in the last 12 months
  • You have been diagnosed with an irregular heart rhythm called atrial fibrillation (AF) in the past 12 months, confirmed by a heart monitor or recording device — either with symptoms, or without symptoms but meeting certain monitoring criteria (confirm with trial site)
  • You are between 18 and 79 years old
  • You are already on, or are being started on, the recommended medications for your type of heart failure
  • You are taking blood thinners to help prevent stroke, as recommended for atrial fibrillation

Who may not be able to join:

  • Your doctors estimate you have less than 1 year to live
  • Your Body Mass Index (BMI) is over 40
  • You cannot take the medications normally used to control heart rate or rhythm (including a drug called amiodarone) due to health reasons or side effects
  • The upper left chamber of your heart is significantly enlarged, based on a heart scan (echocardiogram) in the past year (confirm with trial site)
  • You have had persistent or permanent atrial fibrillation for more than 1 year
  • You have previously had a procedure or surgery to treat atrial fibrillation
  • Your atrial fibrillation has a temporary or reversible cause, such as a recent infection, untreated thyroid problems, or recent surgery
  • You have severe disease affecting your heart valves
  • You have had a heart attack, heart or chest surgery, or stroke in the past 3 months
  • You have heart or chest surgery planned in the near future
  • You are on a waiting list for a heart transplant
  • You have a medical reason why you cannot take blood thinners or have a catheter-based procedure
  • You have severe kidney disease (stage 5 chronic kidney disease)
  • You are pregnant
  • You are not willing to try medication to manage your atrial fibrillation
  • You are unwilling or unable to give your consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sam Riahi, MD, PhD, Department of Cardiology, Aalborg Univeristy Hospital

Phone: +45 40177181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aalborg University Hospital
Registry
ClinicalTrials.gov
Start date
28 August 2024
Est. completion
31 August 2029

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Time to hospitalization for worsening HF or cardiovascular death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov